Phosphonate and phosphinate analogues of N-acylated gamma-glutamylglutamate. potent inhibitors of glutamate carboxypeptidase II. (Q44071205)

29 November 2017

Phosphonate and phosphinate analogues of N-acylated gamma-glutamylglutamate. potent inhibitors of glutamate carboxypeptidase II. (English)

1 reference

29 November 2017

Takashi Tsukamoto

1

1 reference

29 November 2017

Juliet M Flanary

2

1 reference

29 November 2017

Camilo Rojas

3

1 reference

29 November 2017

Barbara S Slusher

4

1 reference

29 November 2017

Nadya Valiaeva

5

1 reference

29 November 2017

James K Coward

6

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

Bioorganic & Medicinal Chemistry Letters

29 November 2017

1 reference

29 November 2017

12

1 reference

29 November 2017

16

1 reference

29 November 2017

2189-2192

1 reference

Role of folylpolygutamate synthetase (FPGS) in antifolate chemotherapy; a biochemical and clinical update

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900360-8

7 January 2021

Dihydrofolate synthetase and folylpolyglutamate synthetase: direct evidence for intervention of acyl phosphate intermediates

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900360-8

7 January 2021

Glutamyl hydrolase. pharmacological role and enzymatic characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900360-8

7 January 2021

Structure of membrane glutamate carboxypeptidase.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900360-8

7 January 2021

Prostate-specific membrane antigen: present and future applications

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900360-8

7 January 2021

NAALADase inhibitors: A novel approach to glutamate regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900360-8

7 January 2021

Design, synthesis, and biological activity of a potent inhibitor of the neuropeptidase N-acetylated alpha-linked acidic dipeptidase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900360-8

7 January 2021

Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900360-8

7 January 2021

Mechanism-based inhibition of human folylpolyglutamate synthetase: design, synthesis, and biochemical characterization of a phosphapeptide mimic of the tetrahedral intermediate

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900360-8

7 January 2021

Phosphinic acid pseudopeptides analogous to glutamyl-gamma-glutamate: synthesis and coupling to pteroyl azides leads to potent inhibitors of folylpoly-gamma-glutamate synthetase.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900360-8

7 January 2021

Design and pharmacological activity of phosphinic acid based NAALADase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900360-8

7 January 2021

Hydrolysis of the neuropeptide N-acetylaspartylglutamate (NAAG) by cloned human glutamate carboxypeptidase II.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900360-8

7 January 2021

Folate-binding triggers the activation of folylpolyglutamate synthetase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900360-8

7 January 2021

Site-directed mutagenesis establishes cysteine-110 as essential for enzyme activity in human gamma-glutamyl hydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900360-8

7 January 2021

Substrate specificity, inhibition and enzymological analysis of recombinant human glutamate carboxypeptidase II.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900360-8

7 January 2021

10.1016/S0960-894X(02)00360-8

Identifiers

DOI

1 reference

29 November 2017

1 reference